Liposome-mediated transient transfection reduces cholesterol-dependent coxsackievirus infectivity

Jerry Wong1, Jingchun Zhang, Guang Gao

  • 1Department of Pathology and Laboratory Medicine, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia-St. Paul's Hospital, Vancouver, Canada.

Insights

Liposome-mediated gene delivery inhibits coxsackievirus B3 replication by preventing viral attachment. This effect, observed across cell types, is linked to membrane cholesterol integrity changes, not depletion.

Area of Science:

  • Molecular Biology
  • Virology
  • Biotechnology

Background:

  • Liposome-mediated gene delivery is crucial for gene function studies and gene therapy.
  • Coxsackievirus B3 is a significant human pathogen causing diverse diseases.

Purpose of the Study:

  • To investigate the impact of liposome-mediated transient transfection on Coxsackievirus B3 replication.
  • To elucidate the mechanism underlying the observed inhibition of viral replication.

Main Methods:

  • Liposome-mediated transient transfection of plasmid cDNA in various cell types.
  • Assessment of viral RNA, protein, and progeny release.
  • Analysis of viral attachment and membrane cholesterol levels.

Main Results:

  • Transient transfection significantly inhibited Coxsackievirus B3 replication at multiple levels.
  • Inhibition was associated with impaired viral attachment.
  • Cholesterol addition partially restored infectivity, suggesting membrane integrity is key.
  • Transfection did not alter overall membrane cholesterol levels, but disrupted its integrity.

Conclusions:

  • Liposome-mediated transfection inhibits Coxsackievirus B3 infectivity by disrupting membrane cholesterol integrity, thereby preventing viral attachment.
  • This finding offers insights into viral entry mechanisms and potential therapeutic strategies.

Related Concept Videos